(levothyroxine sodium tablets) was the 1st
FDA-Approved orally administered levothyroxine sodium treatment for hypothyroidism. UNITHROID tablets have been manufactured in the same facility in New York for more than 2 decades with no history of recalls, reformulations, or gaps in availability. UNITHROID is available in 12 strengths that are therapeutically equivalent to other branded synthetic levothyroxine products. In addition, with UNITHROID’s patient savings program, more than 90% of eligible commercially insured patients may pay as little as $3 for a 30-day prescription.
By delivering quality, consistency, and affordability, all in one, UNITHROID can help get your patients where they need to be no matter which way life turns.
Please see Full Prescribing Information, including Boxed Warning at UnithroidHCP.com.